speb/financial-data huggingface dataset:
CSAI balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1119000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 1119000.00
CSAI balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 80000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 80000.00
CSAI balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1000.00
CSAI income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -6191000.00
CSAI income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: -1171000.00
CSAI income_statement (annual, 2024-12-31) — Total Unusual Items: -426000.00
CSAI income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -426000.00
CSAI balance_sheet (annual, 2024-12-31) — Working Capital: -583000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Working Capital: -583000.00
CSAI income_statement (quarterly, 2025-03-31) — +Operating Expense: 2768000.00
CSAI income_statement (quarterly, 2025-03-31) — +Total Revenue: 737000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 461000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 537000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 50254000.00
CSAI income_statement (quarterly, 2025-03-31) — Basic Average Shares: 15911403.00
CSAI income_statement (quarterly, 2025-03-31) — Basic EPS: -0.15
CSAI cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 52000.00
CSAI cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -30000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 6897000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 6897000.00
CSAI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 9276000.00
CSAI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -30000.00
CSAI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -2401000.00
CSAI cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -167000.00
CSAI cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 0.00
CSAI cash_flow (quarterly, 2025-03-31) — Change In Inventory: -16000.00
CSAI cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -166000.00
CSAI cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 77000.00
CSAI cash_flow (quarterly, 2025-03-31) — Change In Payable: -167000.00
CSAI cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -167000.00
CSAI cash_flow (quarterly, 2025-03-31) — Change In Receivables: -341000.00
CSAI cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -613000.00
CSAI cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -341000.00
CSAI cash_flow (quarterly, 2025-03-31) — Changes In Cash: 6845000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Common Stock: 2000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 6887000.00
CSAI cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
CSAI income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 408000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 0.00
CSAI balance_sheet (quarterly, 2025-03-31) — Current Assets: 7902000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 566000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 566000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1110000.00
CSAI cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 15000.00
CSAI cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 15000.00
CSAI income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 15911403.00
CSAI income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.15
CSAI income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -2316000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 83000.00
CSAI income_statement (quarterly, 2025-03-31) — EBIT: -2438000.00
CSAI income_statement (quarterly, 2025-03-31) — EBITDA: -2423000.00
CSAI cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 0.00
CSAI cash_flow (quarterly, 2025-03-31) — End Cash Position: 6897000.00
CSAI cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 9276000.00
CSAI cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -2431000.00
CSAI cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -415000.00
CSAI income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 415000.00
CSAI income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1082000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 0.00
CSAI income_statement (quarterly, 2025-03-31) — Gross Profit: 330000.00
CSAI income_statement (quarterly, 2025-03-31) — Interest Income: 9000.00
CSAI income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 9000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Inventory: 265000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Invested Capital: 6887000.00
CSAI cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -30000.00
CSAI cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 10750000.00
CSAI cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
CSAI income_statement (quarterly, 2025-03-31) — Net Income: -2015000.00
CSAI income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -2316000.00
CSAI income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -2014000.00
CSAI income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -2015000.00
CSAI income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -2015000.00
CSAI cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -2015000.00
CSAI income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -2014000.00
CSAI cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: 0.00
CSAI income_statement (quarterly, 2025-03-31) — Net Interest Income: 9000.00
CSAI income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 9000.00
CSAI cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -1474000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Net PPE: 96000.00
CSAI cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -30000.00
CSAI cash_flow (quarterly, 2025-03-31) — Net Preferred Stock Issuance: 10750000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 6887000.00
CSAI income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -2838000.00
CSAI income_statement (quarterly, 2025-03-31) — Normalized Income: -2430000.00
CSAI cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -2401000.00
CSAI cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -415000.00
CSAI income_statement (quarterly, 2025-03-31) — Operating Income: -2438000.00
CSAI income_statement (quarterly, 2025-03-31) — Operating Revenue: 531000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 15911403.00
CSAI balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 203000.00
CSAI income_statement (quarterly, 2025-03-31) — Other Gand A: 1082000.00
CSAI income_statement (quarterly, 2025-03-31) — Other Income Expense: 415000.00
CSAI income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 103000.00
CSAI income_statement (quarterly, 2025-03-31) — Other Taxes: 2000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Payables: 544000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 544000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CSAI income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 301000.00
CSAI cash_flow (quarterly, 2025-03-31) — Preferred Stock Issuance: 10750000.00
CSAI income_statement (quarterly, 2025-03-31) — Pretax Income: -2014000.00
CSAI cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: 0.00
CSAI cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -30000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Receivables: 537000.00
CSAI income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 408000.00
CSAI income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 15000.00
CSAI income_statement (quarterly, 2025-03-31) — Research And Development: 769000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -43369000.00
CSAI income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 812000.00
CSAI income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1894000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Share Issued: 15911403.00
CSAI income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
CSAI cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 627000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 6887000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 6887000.00
CSAI income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CSAI income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
CSAI balance_sheet (quarterly, 2025-03-31) — Total Assets: 7998000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 6887000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 6887000.00
CSAI income_statement (quarterly, 2025-03-31) — Total Expenses: 3176000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1111000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 96000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1000.00
CSAI income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -2436000.00
CSAI income_statement (quarterly, 2025-03-31) — Total Unusual Items: 415000.00
CSAI income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 415000.00
CSAI balance_sheet (quarterly, 2025-03-31) — Working Capital: 6792000.00
CSAI income_statement (quarterly, 2025-06-30) — +Operating Expense: 2325000.00
CSAI income_statement (quarterly, 2025-06-30) — +Total Revenue: 1090000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 154000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 496000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 53478000.00
CSAI income_statement (quarterly, 2025-06-30) — Basic Average Shares: 14364286.00
CSAI income_statement (quarterly, 2025-06-30) — Basic EPS: -0.14
CSAI cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 6897000.00
CSAI cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -120000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 7733000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 7733000.00
CSAI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 2861000.00
CSAI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -120000.00
CSAI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -1906000.00
CSAI cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -307000.00
CSAI cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 0.00
CSAI cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -183000.00
CSAI cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 88000.00
CSAI cash_flow (quarterly, 2025-06-30) — Change In Payable: -307000.00
CSAI cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -307000.00
CSAI cash_flow (quarterly, 2025-06-30) — Change In Receivables: 41000.00
CSAI cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -345000.00
CSAI cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 41000.00
CSAI cash_flow (quarterly, 2025-06-30) — Changes In Cash: 836000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Common Stock: 2000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 8060000.00
CSAI income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 686000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 0.00
CSAI balance_sheet (quarterly, 2025-06-30) — Current Assets: 8864000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 654000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 654000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1002000.00
CSAI cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 17000.00
CSAI cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 17000.00
CSAI income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 14364286.00
CSAI income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.14
CSAI income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -2011000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 194000.00
CSAI income_statement (quarterly, 2025-06-30) — EBIT: -1921000.00
CSAI income_statement (quarterly, 2025-06-30) — EBITDA: -1904000.00
CSAI cash_flow (quarterly, 2025-06-30) — End Cash Position: 7733000.00
CSAI cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 2861000.00
CSAI cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -2025000.00
CSAI income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -162000.00
CSAI income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 636000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 0.00
CSAI income_statement (quarterly, 2025-06-30) — Gross Profit: 404000.00
CSAI income_statement (quarterly, 2025-06-30) — Interest Income: 73000.00
CSAI income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 73000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Inventory: 385000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Invested Capital: 8060000.00
CSAI cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -120000.00
CSAI cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 3000000.00
CSAI income_statement (quarterly, 2025-06-30) — Net Income: -2011000.00
CSAI income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -2011000.00
CSAI income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -2010000.00
CSAI income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -2011000.00
CSAI income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -2011000.00
CSAI cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -2549000.00
CSAI income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -2010000.00
CSAI cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: 0.00
CSAI income_statement (quarterly, 2025-06-30) — Net Interest Income: 73000.00
CSAI income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 73000.00
CSAI cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -139000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Net PPE: 198000.00
CSAI cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -120000.00
CSAI cash_flow (quarterly, 2025-06-30) — Net Preferred Stock Issuance: 3000000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 8060000.00
CSAI income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -1742000.00
CSAI income_statement (quarterly, 2025-06-30) — Normalized Income: -1849000.00
CSAI cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -1905000.00
CSAI income_statement (quarterly, 2025-06-30) — Operating Income: -1921000.00
CSAI income_statement (quarterly, 2025-06-30) — Operating Revenue: 1090000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 17589225.00
CSAI balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 250000.00
CSAI income_statement (quarterly, 2025-06-30) — Other Gand A: 636000.00
CSAI income_statement (quarterly, 2025-06-30) — Other Income Expense: -162000.00
CSAI income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 581000.00
CSAI income_statement (quarterly, 2025-06-30) — Other Taxes: 1000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Payables: 348000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 348000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CSAI cash_flow (quarterly, 2025-06-30) — Preferred Stock Issuance: 3000000.00
CSAI income_statement (quarterly, 2025-06-30) — Pretax Income: -2010000.00
CSAI cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: 0.00
CSAI cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -120000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Receivables: 496000.00
CSAI income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 686000.00
CSAI income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 17000.00
CSAI income_statement (quarterly, 2025-06-30) — Research And Development: 379000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -45420000.00
CSAI income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 728000.00
CSAI income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1364000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Share Issued: 17589225.00
CSAI income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
CSAI cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 556000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 8060000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 8060000.00
CSAI income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CSAI income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
CSAI balance_sheet (quarterly, 2025-06-30) — Total Assets: 9062000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 8060000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 8060000.00
CSAI income_statement (quarterly, 2025-06-30) — Total Expenses: 3011000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1002000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 198000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CSAI income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -1921000.00
CSAI income_statement (quarterly, 2025-06-30) — Total Unusual Items: -162000.00
CSAI income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -162000.00
CSAI balance_sheet (quarterly, 2025-06-30) — Working Capital: 7862000.00
CSAI income_statement (quarterly, 2025-09-30) — +Operating Expense: 2703000.00
CSAI income_statement (quarterly, 2025-09-30) — +Total Revenue: 1450471.00
CSAI balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 199000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1388000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 54275000.00
CSAI income_statement (quarterly, 2025-09-30) — Basic Average Shares: 15884615.00
CSAI income_statement (quarterly, 2025-09-30) — Basic EPS: -0.13
CSAI cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 7733000.00
CSAI cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -106000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Capital Stock: 2000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 6403000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 6403000.00
CSAI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 129000.00
CSAI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -106000.00
CSAI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -1350000.00
CSAI cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 45000.00
CSAI cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 174000.00
CSAI cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 18000.00
CSAI cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 709000.00
CSAI cash_flow (quarterly, 2025-09-30) — Change In Payable: 45000.00
CSAI cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 219000.00
CSAI cash_flow (quarterly, 2025-09-30) — Change In Receivables: -892000.00
CSAI cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 54000.00
CSAI cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -892000.00
CSAI cash_flow (quarterly, 2025-09-30) — Changes In Cash: -1330000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Common Stock: 2000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 6793000.00
CSAI income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 731000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 174000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Current Assets: 8409000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 1363000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 1363000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1892000.00
CSAI cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 28000.00
CSAI cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 28000.00
CSAI income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 15884615.00
CSAI income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.13
CSAI income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -2065000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Dividends Payable: 157000.00
CSAI income_statement (quarterly, 2025-09-30) — EBIT: -1983000.00
CSAI income_statement (quarterly, 2025-09-30) — EBITDA: -1955000.00
CSAI cash_flow (quarterly, 2025-09-30) — End Cash Position: 6403000.00
CSAI cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 129000.00
CSAI cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -1459000.00
CSAI income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -144000.00
CSAI income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 504000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 0.00
CSAI income_statement (quarterly, 2025-09-30) — Gross Profit: 720000.00
CSAI income_statement (quarterly, 2025-09-30) — Interest Income: 65000.00
CSAI income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 65000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Inventory: 322000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Invested Capital: 6793000.00
CSAI cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -106000.00
CSAI cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 105000.00
CSAI income_statement (quarterly, 2025-09-30) — Net Income: -2065000.00
CSAI income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -2065000.00
CSAI income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -2062000.00
CSAI income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -2065000.00
CSAI income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -2065000.00
CSAI cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -2064000.00
CSAI income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -2062000.00
CSAI cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: 0.00
CSAI income_statement (quarterly, 2025-09-30) — Net Interest Income: 65000.00
CSAI income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 65000.00
CSAI cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 24000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Net PPE: 276000.00
CSAI cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -106000.00
CSAI cash_flow (quarterly, 2025-09-30) — Net Preferred Stock Issuance: 0.00
CSAI balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 6793000.00
CSAI income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -1811000.00
CSAI income_statement (quarterly, 2025-09-30) — Normalized Income: -1921000.00
CSAI cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -1353000.00
CSAI income_statement (quarterly, 2025-09-30) — Operating Income: -1983000.00
CSAI income_statement (quarterly, 2025-09-30) — Operating Revenue: 771425.00
CSAI balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 19580512.00
CSAI balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 296000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: -1000.00
CSAI income_statement (quarterly, 2025-09-30) — Other Gand A: 504000.00
CSAI income_statement (quarterly, 2025-09-30) — Other Income Expense: -144000.00
CSAI cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -3000.00
CSAI income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 785000.00
CSAI income_statement (quarterly, 2025-09-30) — Other Taxes: 0.00
CSAI balance_sheet (quarterly, 2025-09-30) — Payables: 356000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 530000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CSAI cash_flow (quarterly, 2025-09-30) — Preferred Stock Issuance: 0.00
CSAI income_statement (quarterly, 2025-09-30) — Pretax Income: -2062000.00
CSAI cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: 0.00
CSAI cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -106000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Receivables: 1388000.00
CSAI income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 731000.00
CSAI income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 28000.00
CSAI income_statement (quarterly, 2025-09-30) — Research And Development: 446000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -47484000.00
CSAI income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 968000.00
CSAI income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1472000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Share Issued: 19580512.00
CSAI cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 632000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 6793000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 6793000.00
CSAI income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CSAI income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
CSAI balance_sheet (quarterly, 2025-09-30) — Total Assets: 8685000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 6793000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 6793000.00
CSAI income_statement (quarterly, 2025-09-30) — Total Expenses: 3434000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1892000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 276000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CSAI income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -1984000.00
CSAI income_statement (quarterly, 2025-09-30) — Total Unusual Items: -144000.00
CSAI income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -144000.00
CSAI balance_sheet (quarterly, 2025-09-30) — Working Capital: 6517000.00
CSAI income_statement (annual, 2025-12-31) — +Operating Expense: 9640000.00
CSAI income_statement (quarterly, 2025-12-31) — +Operating Expense: 1842000.00
CSAI income_statement (annual, 2025-12-31) — +Total Revenue: 5066000.00
CSAI income_statement (quarterly, 2025-12-31) — +Total Revenue: 1788000.00
CSAI balance_sheet (annual, 2025-12-31) — Accounts Payable: 531000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 531000.00
CSAI balance_sheet (annual, 2025-12-31) — Accounts Receivable: 874000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 874000.00
CSAI balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 60191000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 60191000.00
CSAI income_statement (annual, 2025-12-31) — Basic Average Shares: 18829585.00
CSAI income_statement (annual, 2025-12-31) — Basic EPS: -0.55
CSAI cash_flow (annual, 2025-12-31) — Beginning Cash Position: 52000.00
CSAI cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 6403000.00
CSAI cash_flow (annual, 2025-12-31) — Capital Expenditure: -315000.00
CSAI cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -59000.00
CSAI balance_sheet (annual, 2025-12-31) — Capital Stock: 2000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2000.00
CSAI balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 8453000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 8453000.00
CSAI balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 8453000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 8453000.00
CSAI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 15633000.00
CSAI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 3367000.00
CSAI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -315000.00
CSAI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -59000.00
CSAI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -6916000.00
CSAI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -1259000.00
CSAI cash_flow (annual, 2025-12-31) — Change In Account Payable: -98000.00
CSAI cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 331000.00
CSAI cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 8000.00
CSAI cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -166000.00
CSAI cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -204000.00
CSAI cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 127000.00
CSAI cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 1000.00
CSAI cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 101000.00
CSAI cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -773000.00
CSAI cash_flow (annual, 2025-12-31) — Change In Payable: -98000.00
CSAI cash_flow (quarterly, 2025-12-31) — Change In Payable: 331000.00
CSAI cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -90000.00
CSAI cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 165000.00
CSAI cash_flow (annual, 2025-12-31) — Change In Receivables: -678000.00
CSAI cash_flow (quarterly, 2025-12-31) — Change In Receivables: 514000.00
CSAI cash_flow (annual, 2025-12-31) — Change In Working Capital: -870000.00
CSAI cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 34000.00
CSAI cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -678000.00
CSAI cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 514000.00
CSAI cash_flow (annual, 2025-12-31) — Changes In Cash: 8401000.00
CSAI cash_flow (quarterly, 2025-12-31) — Changes In Cash: 2050000.00
CSAI balance_sheet (annual, 2025-12-31) — Common Stock: 2000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Common Stock: 2000.00
CSAI balance_sheet (annual, 2025-12-31) — Common Stock Equity: 8910000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 8910000.00
CSAI cash_flow (annual, 2025-12-31) — Common Stock Issuance: 128000.00
CSAI cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 23000.00
CSAI income_statement (annual, 2025-12-31) — Cost Of Revenue: 3577000.00
CSAI income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1752000.00
CSAI balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 8000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 8000.00
CSAI balance_sheet (annual, 2025-12-31) — Current Assets: 9817000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Current Assets: 9817000.00
CSAI balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 590000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 590000.00
CSAI balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 590000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 590000.00
CSAI balance_sheet (annual, 2025-12-31) — Current Liabilities: 1212000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1212000.00
CSAI cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 89000.00
CSAI cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 29000.00
CSAI cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 89000.00
CSAI cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 29000.00
CSAI income_statement (annual, 2025-12-31) — Diluted Average Shares: 18829585.00
CSAI income_statement (annual, 2025-12-31) — Diluted EPS: -0.55
CSAI income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -8462000.00
CSAI income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -1834000.00
CSAI balance_sheet (annual, 2025-12-31) — Dividends Payable: 83000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 83000.00
CSAI income_statement (annual, 2025-12-31) — EBIT: -8151000.00
CSAI income_statement (quarterly, 2025-12-31) — EBIT: -1807000.00
CSAI income_statement (annual, 2025-12-31) — EBITDA: -8062000.00
CSAI income_statement (quarterly, 2025-12-31) — EBITDA: -1778000.00
CSAI cash_flow (annual, 2025-12-31) — End Cash Position: 8453000.00
CSAI cash_flow (quarterly, 2025-12-31) — End Cash Position: 8453000.00
CSAI cash_flow (annual, 2025-12-31) — Financing Cash Flow: 15633000.00
CSAI cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 3367000.00
CSAI cash_flow (annual, 2025-12-31) — Free Cash Flow: -7232000.00
CSAI cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -1317000.00
CSAI income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -515000.00
CSAI income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -86000.00
CSAI balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -2000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -2000.00
CSAI income_statement (annual, 2025-12-31) — General And Administrative Expense: 2439000.00
CSAI income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 586000.00
CSAI income_statement (annual, 2025-12-31) — Gross Profit: 1489000.00
CSAI income_statement (quarterly, 2025-12-31) — Gross Profit: 35000.00
CSAI income_statement (annual, 2025-12-31) — Interest Income: 203000.00
CSAI income_statement (quarterly, 2025-12-31) — Interest Income: 56000.00
CSAI income_statement (annual, 2025-12-31) — Interest Income Non Operating: 203000.00
CSAI income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 56000.00
CSAI balance_sheet (annual, 2025-12-31) — Inventory: 304000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Inventory: 304000.00
CSAI balance_sheet (annual, 2025-12-31) — Invested Capital: 8910000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Invested Capital: 8910000.00
CSAI cash_flow (annual, 2025-12-31) — Investing Cash Flow: -315000.00
CSAI cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -59000.00
CSAI cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 17378000.00
CSAI cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 3523000.00
CSAI cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 128000.00
CSAI cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 23000.00
CSAI cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -2000.00
CSAI income_statement (annual, 2025-12-31) — Net Income: -8462000.00
CSAI income_statement (quarterly, 2025-12-31) — Net Income: -1834000.00
CSAI income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -8462000.00
CSAI income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -1834000.00
CSAI income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -8463000.00
CSAI income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -1837000.00
CSAI income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -8462000.00
CSAI income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1834000.00
CSAI income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -8462000.00
CSAI income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1834000.00
CSAI cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -8462000.00
CSAI cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -1834000.00
CSAI income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -8463000.00
CSAI income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -1837000.00
CSAI income_statement (annual, 2025-12-31) — Net Interest Income: 203000.00
CSAI income_statement (quarterly, 2025-12-31) — Net Interest Income: 56000.00
CSAI income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 203000.00
CSAI income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 56000.00
CSAI cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -1745000.00
CSAI cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -156000.00
CSAI balance_sheet (annual, 2025-12-31) — Net PPE: 305000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Net PPE: 305000.00
CSAI cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -315000.00
CSAI cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -59000.00
CSAI cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 17250000.00
CSAI cash_flow (quarterly, 2025-12-31) — Net Preferred Stock Issuance: 3500000.00
CSAI balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 8910000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 8910000.00
CSAI income_statement (annual, 2025-12-31) — Normalized EBITDA: -7547000.00
CSAI income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -1692000.00
CSAI income_statement (annual, 2025-12-31) — Normalized Income: -7947000.00
CSAI income_statement (quarterly, 2025-12-31) — Normalized Income: -1748000.00
CSAI cash_flow (annual, 2025-12-31) — Operating Cash Flow: -6917000.00
CSAI cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -1258000.00
CSAI cash_flow (annual, 2025-12-31) — Operating Gains Losses: -2000.00
CSAI income_statement (annual, 2025-12-31) — Operating Income: -8151000.00
CSAI income_statement (quarterly, 2025-12-31) — Operating Income: -1807000.00
CSAI income_statement (annual, 2025-12-31) — Operating Revenue: 5066000.00
CSAI income_statement (quarterly, 2025-12-31) — Operating Revenue: 1788000.00
CSAI balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 23911198.00
CSAI balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 23911198.00
CSAI balance_sheet (annual, 2025-12-31) — Other Current Assets: 186000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 186000.00
CSAI balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -2000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -2000.00
CSAI income_statement (annual, 2025-12-31) — Other Gand A: 2439000.00
CSAI income_statement (quarterly, 2025-12-31) — Other Gand A: 586000.00
CSAI income_statement (annual, 2025-12-31) — Other Income Expense: -515000.00
CSAI income_statement (quarterly, 2025-12-31) — Other Income Expense: -86000.00
CSAI cash_flow (annual, 2025-12-31) — Other Non Cash Items: -1000.00
CSAI cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1000.00
CSAI income_statement (annual, 2025-12-31) — Other Operating Expenses: 2432000.00
CSAI income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 430000.00
CSAI income_statement (annual, 2025-12-31) — Other Taxes: 4000.00
CSAI income_statement (quarterly, 2025-12-31) — Other Taxes: 0.00
CSAI balance_sheet (annual, 2025-12-31) — Payables: 614000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Payables: 614000.00
CSAI balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 622000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 622000.00
CSAI balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CSAI balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CSAI cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 17250000.00
CSAI cash_flow (quarterly, 2025-12-31) — Preferred Stock Issuance: 3500000.00
CSAI income_statement (annual, 2025-12-31) — Pretax Income: -8463000.00
CSAI income_statement (quarterly, 2025-12-31) — Pretax Income: -1837000.00
CSAI cash_flow (annual, 2025-12-31) — Purchase Of PPE: -315000.00
CSAI cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -59000.00
CSAI balance_sheet (annual, 2025-12-31) — Receivables: 874000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Receivables: 874000.00
CSAI income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 3577000.00
CSAI income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1752000.00
CSAI income_statement (annual, 2025-12-31) — Reconciled Depreciation: 89000.00
CSAI income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 29000.00
CSAI income_statement (annual, 2025-12-31) — Research And Development: 1883000.00
CSAI income_statement (quarterly, 2025-12-31) — Research And Development: 452000.00
CSAI balance_sheet (annual, 2025-12-31) — Retained Earnings: -51281000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -51281000.00
CSAI income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 2882000.00
CSAI income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 374000.00
CSAI income_statement (annual, 2025-12-31) — Selling General And Administration: 5321000.00
CSAI income_statement (quarterly, 2025-12-31) — Selling General And Administration: 960000.00
CSAI balance_sheet (annual, 2025-12-31) — Share Issued: 23911198.00
CSAI balance_sheet (quarterly, 2025-12-31) — Share Issued: 23911198.00
CSAI income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
CSAI cash_flow (annual, 2025-12-31) — Stock Based Compensation: 2329000.00
CSAI cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 514000.00
CSAI balance_sheet (annual, 2025-12-31) — Stockholders Equity: 8910000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 8910000.00
CSAI balance_sheet (annual, 2025-12-31) — Tangible Book Value: 8910000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 8910000.00
CSAI income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CSAI income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CSAI income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
CSAI income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
CSAI balance_sheet (annual, 2025-12-31) — Total Assets: 10122000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Total Assets: 10122000.00
CSAI balance_sheet (annual, 2025-12-31) — Total Capitalization: 8910000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 8910000.00
CSAI balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 8910000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 8910000.00
CSAI income_statement (annual, 2025-12-31) — Total Expenses: 13217000.00
CSAI income_statement (quarterly, 2025-12-31) — Total Expenses: 3594000.00
CSAI balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1212000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1212000.00
CSAI balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 305000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 305000.00
CSAI balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CSAI balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CSAI income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -8147000.00
CSAI income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -1807000.00
CSAI income_statement (annual, 2025-12-31) — Total Unusual Items: -515000.00
CSAI income_statement (quarterly, 2025-12-31) — Total Unusual Items: -86000.00
CSAI income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -515000.00
CSAI income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -86000.00
CSAI balance_sheet (annual, 2025-12-31) — Working Capital: 8605000.00
CSAI balance_sheet (quarterly, 2025-12-31) — Working Capital: 8605000.00
CSAI income_statement (quarterly, 2026-03-31) — +Operating Expense: 3396000.00
CSAI income_statement (quarterly, 2026-03-31) — +Total Revenue: 1315000.00
CSAI balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 405000.00
CSAI balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 917000.00
CSAI balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 54714000.00
CSAI income_statement (quarterly, 2026-03-31) — Basic Average Shares: 23759259.00
CSAI income_statement (quarterly, 2026-03-31) — Basic EPS: -0.14
CSAI cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 8453000.00
CSAI cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -58000.00
CSAI balance_sheet (quarterly, 2026-03-31) — Capital Stock: 4203000.00
CSAI balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 5750000.00
CSAI balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 5750000.00
CSAI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -129000.00
CSAI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -58000.00
CSAI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -2513000.00
CSAI cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -126000.00
CSAI cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 41000.00
CSAI cash_flow (quarterly, 2026-03-31) — Change In Inventory: 17000.00
CSAI cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -296000.00
CSAI cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 102000.00
CSAI cash_flow (quarterly, 2026-03-31) — Change In Payable: -126000.00
CSAI cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -85000.00
CSAI cash_flow (quarterly, 2026-03-31) — Change In Receivables: -43000.00
CSAI cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -305000.00
CSAI cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -43000.00
CSAI cash_flow (quarterly, 2026-03-31) — Changes In Cash: -2700000.00
CSAI balance_sheet (quarterly, 2026-03-31) — Common Stock: 3000.00
CSAI balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 904000.00
CSAI cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 11000.00
CSAI income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 605000.00